October 2022
1. BLAIR HA
   Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis.
   Drugs. 2022 Oct 18. pii: 10.1007/s40265-022-01791.
   

   >> Share

   
   June 2022
2. LAMB YN
   Correction to: Nirmatrelvir Plus Ritonavir: First Approval.
   Drugs. 2022 Jun 11. pii: 10.1007/s40265-022-01737.
   

   >> Share

   
   March 2022
3. LAMB YN
   Nirmatrelvir Plus Ritonavir: First Approval.
   Drugs. 2022 Mar 19. pii: 10.1007/s40265-022-01692.
   

   >> Share

   
   January 2021
4. SHAH S, Hindley L, Hill A
   Are New Antiretroviral Treatments Increasing the Risk of Weight Gain?
   Drugs. 2021 Jan 5. pii: 10.1007/s40265-020-01457.
   

   >> Share

   
   October 2020
5. CANTINI F, Goletti D, Petrone L, Najafi Fard S, et al
   Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
   Drugs. 2020 Oct 17. pii: 10.1007/s40265-020-01421.
   

   >> Share

   
   
6. MUJUGIRA A, Baeten JM, Hodges-Mameletzis I, Haberer JE, et al
   Lamivudine/Tenofovir Disoproxil Fumarate is an Appropriate PrEP Regimen.
   Drugs. 2020 Oct 10. pii: 10.1007/s40265-020-01419.
   

   >> Share

   
   August 2020
7. SCARSI KK, Havens JP, Podany AT, Avedissian SN, et al
   HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.
   Drugs. 2020 Aug 29. pii: 10.1007/s40265-020-01379.
   

   >> Share

   
   December 2019
8. SCOTT LJ
   Dolutegravir/Lamivudine Single-Tablet Regimen: A Review in HIV-1 Infection.
   Drugs. 2019 Dec 21. pii: 10.1007/s40265-019-01247.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share